Capricor Therapeutics Inc (CAPR)
Healthcare
Biotechnology
3.90 $
-8.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Capricor Therapeutics Inc (CAPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -70 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.0 | -11 | -16 | -14 | -14 | -6.8 | -10 | -17 | 4.9 | -26 | -40 | -70 | |
| 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.2 | 0.5 | 1.1 | 1.4 | 1.9 | |
| 0.5 | 1.6 | 2.0 | 1.7 | 1.7 | 0.7 | 2.0 | 3.0 | 4.5 | 7.4 | 9.8 | 17 | |
| 0.5 | 1.6 | 3.5 | 1.7 | 1.7 | 0.7 | 2.0 | 2.8 | 4.5 | – | – | – | |
| 6.6 | 0.4 | -0.6 | -2.9 | -0.6 | -0.1 | 1.5 | 0.2 | 29 | -12 | -11 | 12 | |
| 0.2 | 0.2 | 0.2 | 0.0 | 0.3 | 0.5 | 0.5 | 1.2 | 3.4 | 2.0 | 1.5 | 2.9 | |
| 0.1 | -8.1 | -5.2 | 5.0 | 4.7 | -3.0 | 5.4 | -1.2 | -35 | 5.1 | -116 | 97 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 0.0 | 16 | 14 | 11 | 6.9 | 0.0 | 33 | 20 | 4.9 | – | – | – | |
| 5.2 | 4.8 | 4.8 | 0.5 | 0.3 | 0.3 | 0.3 | 0.0 | – | – | – | – | |
| 5.2 | 16 | 19 | 12 | 6.9 | 9.2 | 33 | 20 | 4.9 | 26 | 153 | 249 | |
| 6.3 | -2.5 | -2.4 | 2.3 | -2.3 | -0.6 | 29 | 2.2 | -25 | 5.1 | -3.4 | 277 | |
| 0.8 | -11 | -16 | -14 | -14 | -6.8 | -11 | -18 | 1.6 | -28 | -42 | -73 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.